Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Superoxide Dismutase | 10 | 2002 | 149 | 0.500 |
Why?
|
| Microbodies | 9 | 1999 | 60 | 0.460 |
Why?
|
| Kidney Calculi | 1 | 2010 | 19 | 0.350 |
Why?
|
| Kidney | 16 | 2004 | 945 | 0.350 |
Why?
|
| Reperfusion Injury | 10 | 2004 | 320 | 0.340 |
Why?
|
| Ischemia | 10 | 2003 | 229 | 0.320 |
Why?
|
| Catalase | 9 | 2002 | 85 | 0.310 |
Why?
|
| Liver | 8 | 2000 | 1118 | 0.300 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 711 | 0.230 |
Why?
|
| Kidney Transplantation | 7 | 2012 | 839 | 0.210 |
Why?
|
| Glycopeptides | 3 | 2003 | 15 | 0.160 |
Why?
|
| Nitroprusside | 3 | 2003 | 42 | 0.160 |
Why?
|
| Glutathione Peroxidase | 6 | 2002 | 39 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 2 | 2012 | 364 | 0.150 |
Why?
|
| Peritoneal Dialysis | 4 | 1992 | 30 | 0.140 |
Why?
|
| Acetylcysteine | 4 | 2004 | 296 | 0.140 |
Why?
|
| Protein S Deficiency | 1 | 1996 | 4 | 0.140 |
Why?
|
| Protein S | 1 | 1996 | 9 | 0.140 |
Why?
|
| Organ Preservation Solutions | 2 | 2004 | 45 | 0.130 |
Why?
|
| Organ Preservation | 2 | 2004 | 69 | 0.130 |
Why?
|
| Nephrotic Syndrome | 1 | 1996 | 61 | 0.130 |
Why?
|
| Rats | 20 | 2010 | 5300 | 0.130 |
Why?
|
| Steroids | 1 | 1996 | 84 | 0.130 |
Why?
|
| Child | 14 | 2012 | 6405 | 0.130 |
Why?
|
| Masked Hypertension | 1 | 2012 | 7 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2010 | 2083 | 0.100 |
Why?
|
| Graft Survival | 3 | 2012 | 465 | 0.100 |
Why?
|
| Male | 31 | 2012 | 37321 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 5 | 2010 | 365 | 0.100 |
Why?
|
| Catheterization | 1 | 1992 | 209 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 49 | 0.090 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 9 | 0.090 |
Why?
|
| Lovastatin | 1 | 2010 | 78 | 0.090 |
Why?
|
| Mycophenolic Acid | 1 | 2010 | 62 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 514 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2010 | 95 | 0.090 |
Why?
|
| Oligodendroglia | 1 | 2010 | 107 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 108 | 0.090 |
Why?
|
| Age of Onset | 1 | 2010 | 188 | 0.090 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 1988 | 43 | 0.090 |
Why?
|
| Glomerulonephritis | 2 | 1988 | 77 | 0.080 |
Why?
|
| Albuminuria | 1 | 2010 | 171 | 0.080 |
Why?
|
| Risk Factors | 4 | 2012 | 5731 | 0.080 |
Why?
|
| Child, Preschool | 5 | 2010 | 3187 | 0.080 |
Why?
|
| Animals | 23 | 2010 | 20881 | 0.080 |
Why?
|
| Stem Cells | 1 | 2010 | 248 | 0.080 |
Why?
|
| Age Factors | 2 | 2010 | 1864 | 0.080 |
Why?
|
| Infant | 5 | 2010 | 2891 | 0.080 |
Why?
|
| Creatinine | 5 | 2010 | 243 | 0.080 |
Why?
|
| Endotoxins | 2 | 2000 | 76 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2004 | 1174 | 0.070 |
Why?
|
| Adolescent | 9 | 2012 | 8912 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2010 | 458 | 0.070 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1986 | 13 | 0.070 |
Why?
|
| Pyelonephritis | 1 | 1986 | 17 | 0.070 |
Why?
|
| Hypertension, Renal | 1 | 1986 | 29 | 0.070 |
Why?
|
| Sex Factors | 1 | 2010 | 1266 | 0.070 |
Why?
|
| Incidence | 1 | 2010 | 1603 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2004 | 25 | 0.060 |
Why?
|
| Female | 12 | 2012 | 38074 | 0.060 |
Why?
|
| Proteinuria | 3 | 2010 | 136 | 0.060 |
Why?
|
| Renal Artery | 1 | 1983 | 29 | 0.060 |
Why?
|
| South Carolina | 1 | 2010 | 2752 | 0.060 |
Why?
|
| Kidney Diseases | 2 | 2003 | 307 | 0.050 |
Why?
|
| Blotting, Western | 4 | 1999 | 954 | 0.050 |
Why?
|
| Fatty Acids | 4 | 1993 | 222 | 0.050 |
Why?
|
| Mitochondria | 5 | 1994 | 643 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 250 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 1983 | 150 | 0.050 |
Why?
|
| Humans | 16 | 2012 | 68618 | 0.050 |
Why?
|
| Clofibric Acid | 3 | 1994 | 12 | 0.040 |
Why?
|
| Raffinose | 2 | 2004 | 28 | 0.040 |
Why?
|
| Allopurinol | 2 | 2004 | 36 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 1997 | 92 | 0.040 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 3 | 1984 | 14 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2000 | 48 | 0.040 |
Why?
|
| Oxidoreductases | 2 | 1997 | 117 | 0.040 |
Why?
|
| Adenosine | 2 | 2004 | 165 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 1994 | 351 | 0.040 |
Why?
|
| Blood Pressure | 3 | 2012 | 1451 | 0.040 |
Why?
|
| Hypertension | 2 | 2010 | 1535 | 0.040 |
Why?
|
| Ethanol | 2 | 1992 | 893 | 0.040 |
Why?
|
| Glutathione | 2 | 2004 | 343 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 562 | 0.040 |
Why?
|
| Oxidation-Reduction | 6 | 2000 | 567 | 0.040 |
Why?
|
| Prevalence | 2 | 2012 | 1619 | 0.040 |
Why?
|
| Insulin | 2 | 2004 | 619 | 0.030 |
Why?
|
| Time Factors | 7 | 2002 | 4655 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 1996 | 15 | 0.030 |
Why?
|
| Membrane Fluidity | 2 | 2000 | 13 | 0.030 |
Why?
|
| Lipid Peroxides | 2 | 2000 | 19 | 0.030 |
Why?
|
| Reperfusion | 2 | 2002 | 78 | 0.030 |
Why?
|
| Thromboembolism | 1 | 1996 | 91 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2004 | 2550 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 507 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 282 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1994 | 17 | 0.030 |
Why?
|
| Renal Veins | 1 | 1994 | 18 | 0.030 |
Why?
|
| Survival Rate | 2 | 2010 | 1056 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 1994 | 82 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1994 | 90 | 0.030 |
Why?
|
| Nephrectomy | 2 | 2004 | 103 | 0.030 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 532 | 0.030 |
Why?
|
| Dogs | 2 | 2004 | 490 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 765 | 0.030 |
Why?
|
| Ischemic Preconditioning | 2 | 2002 | 31 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 89 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1994 | 499 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 536 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2003 | 649 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 147 | 0.020 |
Why?
|
| Equipment Design | 1 | 1992 | 500 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 114 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1994 | 718 | 0.020 |
Why?
|
| Thioridazine | 1 | 1990 | 6 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 792 | 0.020 |
Why?
|
| Renal Circulation | 1 | 1990 | 49 | 0.020 |
Why?
|
| Fibric Acids | 3 | 1994 | 12 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 242 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2010 | 120 | 0.020 |
Why?
|
| Models, Biological | 1 | 1994 | 981 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 396 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 626 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 1992 | 2455 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 7029 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1992 | 232 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1988 | 10 | 0.020 |
Why?
|
| Nephrosis, Lipoid | 1 | 1988 | 9 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2010 | 205 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 212 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 1664 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 317 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1989 | 314 | 0.020 |
Why?
|
| Transplantation, Autologous | 2 | 2004 | 145 | 0.020 |
Why?
|
| Growth | 2 | 1984 | 17 | 0.020 |
Why?
|
| Antioxidants | 2 | 2002 | 304 | 0.020 |
Why?
|
| von Willebrand Diseases | 1 | 1987 | 11 | 0.020 |
Why?
|
| Hematuria | 1 | 1987 | 24 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 1641 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1420 | 0.020 |
Why?
|
| Random Allocation | 2 | 2003 | 442 | 0.020 |
Why?
|
| NADH Dehydrogenase | 2 | 1997 | 13 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1994 | 1615 | 0.020 |
Why?
|
| Electron Transport Complex IV | 2 | 1997 | 33 | 0.020 |
Why?
|
| Cicatrix | 1 | 1986 | 60 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2673 | 0.020 |
Why?
|
| Cell Compartmentation | 2 | 1994 | 41 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 2004 | 26 | 0.020 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1984 | 6 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 1984 | 22 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 1984 | 40 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 2358 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 201 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 2279 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 163 | 0.010 |
Why?
|
| Urography | 1 | 1983 | 21 | 0.010 |
Why?
|
| Infarction | 1 | 1983 | 17 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1984 | 174 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 71 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 61 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 160 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 194 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 191 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 245 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 140 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2002 | 114 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2000 | 17 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2000 | 75 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 189 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1200 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 254 | 0.010 |
Why?
|
| Gadolinium | 1 | 2000 | 88 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1997 | 17 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2000 | 455 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1997 | 137 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 167 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 492 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1996 | 308 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1994 | 234 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1994 | 6 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1994 | 155 | 0.010 |
Why?
|
| Amitrole | 1 | 1993 | 4 | 0.010 |
Why?
|
| Acyl-CoA Oxidase | 1 | 1993 | 12 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1993 | 34 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1994 | 166 | 0.010 |
Why?
|
| Peritonitis | 2 | 1984 | 46 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1993 | 94 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1994 | 236 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 168 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 36 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 218 | 0.010 |
Why?
|
| Organelles | 1 | 1992 | 18 | 0.010 |
Why?
|
| Reoperation | 1 | 1994 | 467 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1990 | 14 | 0.010 |
Why?
|
| Epithelium | 1 | 1990 | 172 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1990 | 81 | 0.010 |
Why?
|
| Myocardium | 1 | 1996 | 1204 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1990 | 186 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1988 | 48 | 0.000 |
Why?
|
| Caprylates | 1 | 1988 | 32 | 0.000 |
Why?
|
| Adult | 2 | 1984 | 21403 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1988 | 104 | 0.000 |
Why?
|
| Homeostasis | 1 | 1990 | 291 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1990 | 222 | 0.000 |
Why?
|
| Bleeding Time | 1 | 1987 | 3 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1990 | 431 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 848 | 0.000 |
Why?
|
| Age Determination by Skeleton | 1 | 1984 | 3 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1984 | 65 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1984 | 71 | 0.000 |
Why?
|
| Prednisone | 1 | 1984 | 104 | 0.000 |
Why?
|
| Energy Intake | 1 | 1984 | 123 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1984 | 78 | 0.000 |
Why?
|
| Body Height | 1 | 1983 | 67 | 0.000 |
Why?
|
| Social Adjustment | 1 | 1983 | 74 | 0.000 |
Why?
|
| Body Weight | 1 | 1983 | 554 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1984 | 7277 | 0.000 |
Why?
|